4//SEC Filing
Asghar Najjam 4
Accession 0001209191-21-021394
CIK 0000850261other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:57 PM ET
Size
7.4 KB
Accession
0001209191-21-021394
Insider Transaction Report
Form 4
Asghar Najjam
Chief Financial Officer
Transactions
- Award
Stock Option
2021-03-16+100,000→ 100,000 totalExercise: $10.18Exp: 2031-03-16→ Common Stock (100,000 underlying) - Award
Common Stock
2021-03-16+56,974→ 56,974 total
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units, 1/4th of which shall vest on March 16, 2022 and 1/4th of which shall vest on each anniversary thereafter.
- [F2]1/4th of the original number of shares subject to the option shall vest on March 16, 2022, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001822126
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:57 PM ET
- Size
- 7.4 KB